← Back to Search

Dietary Supplement

Iron Supplementation for Blood Donation (UH3BLIS Trial)

N/A
Recruiting
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
individuals between 18 - 60 years who weigh at least 50kg
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

UH3BLIS Trial Summary

This trial will compare the effectiveness of low-dose iron supplementation among blood donors who were deferred due to low hemoglobin levels but meet all other requirements, to a group of donors who were deferred and only

Who is the study for?
This trial is for individuals aged 18-60, weighing at least 50kg, who meet the physical criteria for blood donation but were deferred due to low haemoglobin. They must understand English, Twi, Ewe, or Ga and be willing to stay in the study for its full length.Check my eligibility
What is being tested?
The trial compares a group taking low-dose iron supplements daily with those receiving only nutrition counseling after being deferred from blood donation due to low haemoglobin. Success is measured by their ability to donate blood within a year.See study design
What are the potential side effects?
Potential side effects of the iron supplementation may include issues with the lower gastrointestinal system. Safety and compliance will be monitored through monthly phone calls.

UH3BLIS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old and weigh at least 50kg.

UH3BLIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants with a successful blood donation
Secondary outcome measures
Proportion of participants who attempt blood donation

UH3BLIS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Iron SupplementationExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of GhanaOTHER
35 Previous Clinical Trials
105,998 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,840 Previous Clinical Trials
47,851,632 Total Patients Enrolled
1 Trials studying Blood Donation
35,000 Patients Enrolled for Blood Donation
University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,283 Total Patients Enrolled
1 Trials studying Blood Donation
35,000 Patients Enrolled for Blood Donation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this medical study currently accepting new participants?

"According to the details provided on clinicaltrials.gov, this ongoing clinical trial is actively seeking participants. The initial posting of the trial was recorded on November 30th, 2023, and it underwent its most recent update on January 4th, 2024."

Answered by AI

What is the current number of individuals who have been granted admission to participate in this clinical study?

"Indeed, the details provided on clinicaltrials.gov affirm that this ongoing clinical trial is actively seeking eligible participants. The initial posting of the trial occurred on November 30th, 2023, and the most recent update was made on January 4th, 2024. A total of 492 patients are being sought at a single designated site."

Answered by AI

Do I meet the criteria to participate in this medical research study?

"To qualify for participation in this trial, individuals must be between the ages of 18 and 60 and meet the criteria for blood donation. The study has a capacity to enroll approximately 492 eligible candidates."

Answered by AI

Are individuals aged 25 years and older eligible to participate in this medical study?

"This investigation is currently seeking individuals who are older than 18 years but younger than 60."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy
2023. "BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06101238.
~328 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top